JP2023530785A5 - - Google Patents
Info
- Publication number
- JP2023530785A5 JP2023530785A5 JP2023519156A JP2023519156A JP2023530785A5 JP 2023530785 A5 JP2023530785 A5 JP 2023530785A5 JP 2023519156 A JP2023519156 A JP 2023519156A JP 2023519156 A JP2023519156 A JP 2023519156A JP 2023530785 A5 JP2023530785 A5 JP 2023530785A5
- Authority
- JP
- Japan
- Prior art keywords
- crystal
- xrpd pattern
- peaks
- irradiation
- degrees
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026034319A JP2026108667A (ja) | 2020-06-08 | 2026-03-04 | {2-[3-シクロヘキシル-3-(trans-4-プロポキシ-シクロヘキシル)-ウレイド]-チアゾール-5-イルスルファニル}-酢酸の結晶形およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063035994P | 2020-06-08 | 2020-06-08 | |
| US63/035,994 | 2020-06-08 | ||
| PCT/US2021/036082 WO2021252309A1 (en) | 2020-06-08 | 2021-06-07 | Crystalline forms of {2-[3-cyclohexyl-3-(trans-4-propoxy- cyclohexyl)-ureido]-thiazol-5-ylsulfanyl} -acetic acid and and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026034319A Division JP2026108667A (ja) | 2020-06-08 | 2026-03-04 | {2-[3-シクロヘキシル-3-(trans-4-プロポキシ-シクロヘキシル)-ウレイド]-チアゾール-5-イルスルファニル}-酢酸の結晶形およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023530785A JP2023530785A (ja) | 2023-07-19 |
| JP2023530785A5 true JP2023530785A5 (cg-RX-API-DMAC7.html) | 2024-06-13 |
Family
ID=78846441
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023519156A Pending JP2023530785A (ja) | 2020-06-08 | 2021-06-07 | {2-[3-シクロヘキシル-3-(trans-4-プロポキシ-シクロヘキシル)-ウレイド]-チアゾール-5-イルスルファニル}-酢酸の結晶形およびその使用 |
| JP2026034319A Pending JP2026108667A (ja) | 2020-06-08 | 2026-03-04 | {2-[3-シクロヘキシル-3-(trans-4-プロポキシ-シクロヘキシル)-ウレイド]-チアゾール-5-イルスルファニル}-酢酸の結晶形およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026034319A Pending JP2026108667A (ja) | 2020-06-08 | 2026-03-04 | {2-[3-シクロヘキシル-3-(trans-4-プロポキシ-シクロヘキシル)-ウレイド]-チアゾール-5-イルスルファニル}-酢酸の結晶形およびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4161639A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2023530785A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230048501A (cg-RX-API-DMAC7.html) |
| CN (2) | CN116056760A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021289591A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3181665A1 (cg-RX-API-DMAC7.html) |
| MX (2) | MX2022015524A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021252309A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3093025A1 (en) | 2018-06-12 | 2019-12-19 | Vtv Therapeutics Llc | Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs |
| US12391658B2 (en) | 2020-02-18 | 2025-08-19 | Vtv Therapeutics Llc | Sulfoxide and sulfone glucokinase activators and methods of use thereof |
| US12479808B2 (en) | 2020-06-08 | 2025-11-25 | Vtv Therapeutics Llc | Salts or co-crystals of {2-[3-cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0506662B8 (pt) * | 2004-01-06 | 2021-05-25 | Novo Nordisk As | compostos ativadores de glucoquinase |
| PT2576524T (pt) * | 2010-05-26 | 2017-11-17 | Vtv Therapeutics Llc | Resumo |
| IN2014DN09554A (cg-RX-API-DMAC7.html) * | 2012-05-17 | 2015-07-17 | Transtech Pharma Llc | |
| CA2903433A1 (en) * | 2013-03-04 | 2014-09-12 | Vtv Therapeutics Llc | Stable glucokinase activator compositions |
| HK1213197A1 (zh) * | 2013-03-04 | 2016-06-30 | Vtv治疗有限责任公司 | 包括葡糖激酶活化劑的固體組合物及其製備和使用方法 |
| DK3556354T3 (da) * | 2016-12-15 | 2025-08-04 | Hua Medicine Shanghai Ltd | Oral fremstilling af en glucokinaseaktivator og fremgangsmåde til fremstilling deraf |
-
2021
- 2021-06-07 CA CA3181665A patent/CA3181665A1/en active Pending
- 2021-06-07 CN CN202180056233.1A patent/CN116056760A/zh active Pending
- 2021-06-07 WO PCT/US2021/036082 patent/WO2021252309A1/en not_active Ceased
- 2021-06-07 KR KR1020237000609A patent/KR20230048501A/ko active Pending
- 2021-06-07 EP EP21821691.9A patent/EP4161639A4/en active Pending
- 2021-06-07 JP JP2023519156A patent/JP2023530785A/ja active Pending
- 2021-06-07 MX MX2022015524A patent/MX2022015524A/es unknown
- 2021-06-07 CN CN202511373032.0A patent/CN121202809A/zh active Pending
- 2021-06-07 AU AU2021289591A patent/AU2021289591A1/en active Pending
-
2022
- 2022-12-06 MX MX2026000786A patent/MX2026000786A/es unknown
-
2026
- 2026-03-04 JP JP2026034319A patent/JP2026108667A/ja active Pending